Gene Expression Market Size Worth $19.4 Billion By 2028

Published On: November 3, 2021

The global gene expression market is estimated to arrive at USD 19.4 billion by 2028. It is projected to develop by 9.96% CAGR from 2021 to 2028.

The growth in funds, used for the enhancement of another method of drug discovery, together with an augmentation in research actions, intended for the genetic learning is likely to steer the global market for gene expression.

An increase in alertness regarding the possible use of genetic learning has initiated a boost in funds, in support of the advancement in addition to the presentation of fresh products. Besides, the reduction in prices linked with sequencing, positioned like a most important driver during the previous few years.

 To request a sample copy or view summary of this report, "please" click the link below:

Further key findings from the report suggest:

• Thermo Fisher Scientific, Inc. presented the Power Track SYBR Green PCR Master Mix for instantaneous PCR workflow, in March 2020. The product is set to intensify the objects for accurate examination

• The major companies like Agilent Technologies and Thermo Fisher Scientific, Inc., have taken on tactical programs, to make stronger their place in the gene expression market

• In 2020, North America was the leading local market. This can be credited to the greater implementation of sophisticated gene expression technology, within the region

• The drug discovery & development section held the major revenue share of the market, in 2020, because Gene Expression Signature (GES) is frequently utilized for the advancement of new molecules, designed for the multi factorial cellular sicknesses similar to AIDS, tuberculosis, cancer, malaria, diabetes, plus additional transmittable sicknesses

• The presentation of greater throughput corroboration technique, for example targeted RNA sequencing that are helpful in broader screening technologies, has augmented the revenue creation, within the section

• As a result of greater implementation of RNA expression analysis, in 2020, RNA expression was the biggest revenue adding method

• High-Plex capacity is projected to record the highest CAGR, throughout the forecast period, because of the greater accurateness plus augmented function in cancer research

• The continuing improvement in the kits and reagents, devoted for the particular purposes adds to the greater share of the section. Because of their augmented use for the duration of the procedure, kits and reagents product created the major revenue, in 2020

• The initiation of the methods that offer straight library synthesis has abolished the necessity for previous steps, that enhances revenue share

• In 2020, cDNA synthesis & conversion led the process section. Greater demand for custom-made medication, together with technical progression in sequencing techniques, has improved the function of cDNA synthesis to create genomic libraries

Million Insights segmented the global gene expression market based on Application, Technique, Capacity, Product, Process, and Region.

Gene Expression Process Outlook (Revenue, USD Million, 2017 - 2028)
    • Sample Collection
    • Purification
    • cDNA Synthesis & Conversion
    • PCR Analysis
    • Data Analysis & Interpretation

Gene Expression Product Outlook (Revenue, USD Million, 2017 - 2028)
    • Kits & Reagents
    • DNA Chip/Microarray
    • Others

Gene Expression Capacity Outlook (Revenue, USD Million, 2017 - 2028)
    • Low- to Mid-Plex
    • High-Plex

Gene Expression Technique Outlook (Revenue, USD Million, 2017 - 2028)
    • RNA Exp.
        • Northern Blotting
        • DNA Microarrays
        • PCR Techniques
        • RNA-Seq
    • Promoter Analysis
        • In vitro Transcription/Nuclear Run-On Assays
        • Gel Shift Assays
        • Chromatin Immunoprecipitation (ChIP) Assays
    • Protein Exp. & Posttranslational Modification Analysis
        • Western Blotting
        • 2-D Gel Electrophoresis
        • Immunoassays
        • Mass Spectrometry

Gene Expression Application Outlook (Revenue, USD Million, 2017 - 2028)
    • Drug Discovery & Development
    • Clinical Diagnostics
        • RNA Exp.
        • Other Techniques
    • Biotechnology & Microbiology
    • Others

Gene Expression Regional Outlook (Revenue, USD Million, 2017 - 2028)
    • North America
        • U.S.
        • Canada
    • Europe
        • Germany
        • France
        • U.K.
        • Italy
        • Spain
    • Asia Pacific
        • Japan
        • China
        • India
        • Australia
        • South Korea
    • Latin America
        • Brazil
        • Mexico
    • Middle East Africa (MEA)
        • South Africa
        • Saudi Arabia


Various companies for gene expression market are:

• Interpace Biosciences, Inc.
• Biocartis NV
• ELITech Group
• Takara Bio, Inc.
• Promega Corp.
• Agilent Technologies
• Bio-Rad Laboratories
• Illumina, Inc.
• Quest Diagnostics, Inc.
• Fluidigm Corp.
• IntegraGen
• AutoGenomics
• Danaher Corp.
• Luminex Corp.
• GE Healthcare
• Thermo Fisher Scientific, Inc.
• PerkinElmer, Inc.
• F. Hoffmann-La Roche Ltd.